http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-038572-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 |
| filingDate | 2003-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5092cde46b2447b74959efcfc2fb8cec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15a4e1f8e85595b23847677515d13631 |
| publicationDate | 2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-038572-A1 |
| titleOfInvention | POWDER INHALATION PRODUCT CONTAINING THE CGRP ANTAGONIST, BIBN4096, AND PROCEDURE FOR PREPARATION |
| abstract | Powder inhalation product for the treatment of migraine, which encompasses the CGRP antagonist 1- [N2- [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxoquinazolin- 3-yl) -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine [BIBN4096] of the formula (1) as the basis of active substance in the form of particles with a spherical nanostructure, as well as a procedure for its preparation. Claim 1: Powder inhalation product covering the base of active principle 1- [N2- [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxoquinazolin-3-yl ) -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine [BIBN4096] of the formula (1) in the form of particles with a spherical nanostructure, characterized in that: ( a) the particles have a spherical surface between 1 m2 / g and 20 m2 / g; (b) the characteristic value Q (5.8) is between 50% and 100%; and (c) parameter X50 is between 1 microns and 6 microns. |
| priorityDate | 2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461 |
Total number of triples: 23.